{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:53:33Z","timestamp":1788310413465,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["SOM2017001 Grant"],"award-info":[{"award-number":["SOM2017001 Grant"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Commercially available antiviral drugs, when used in the treatment of viral infections, do not always result in success. This is an urgent problem currently that needs to be addressed because several viruses including influenza and paramyxoviruses are acquiring multi-drug resistance. A potential solution for this emerging issue is to create new antiviral drugs from available compounds of natural products. It is known that the majority of drugs have been developed using compounds derived from actinomycetes, which are naturally occurring gram-positive bacteria. The purpose of this study was to investigate the antiviral properties of extremophilic actinomycetes extracts from strains that were isolated from extreme environments in Kazakhstan.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Five strains of extremophilic actinomycetes isolated from the unique ecosystems of Kazakhstan were extracted and tested for antiviral activity against influenza viruses (strains H7N1, H5N3, H1N1 and H3N2) and paramyxoviruses (Sendai Virus and Newcastle Disease Virus). The antiviral activity of these selected extracts was tested by checking their effect on hemagglutination and neuraminidase activities of the studied viruses. Additionally, actinomycetes extracts were compared with commercially available antiviral drugs and some plant preparations that have been shown to exhibit antiviral properties.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The main findings show that extracts from strains K-192, K-340, K-362, K-522 and K525 showed antiviral activities when tested using influenza viruses, Sendai Virus, and Newcastle Disease Virus. These activities were comparable to those shown by Rimantadine and Tamiflu drugs, and \u201cVirospan\u201d and \u201cFlavovir\u201d plant preparations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We identified several extracts with antiviral activities against several strains of influenza viruses and paramyxoviruses. Our research findings can be applied towards characterization and development of new antiviral drugs from the active actinomycetes extracts.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12985-019-1254-1","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T12:04:07Z","timestamp":1575288247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan\u2019s unique ecosystems against influenza viruses and paramyxoviruses"],"prefix":"10.1186","volume":"16","author":[{"given":"Vladimir","family":"Berezin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyora","family":"Abdukhakimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Trenozhnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Bogoyavlenskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizhan","family":"Turmagambetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpamys","family":"Issanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-0490","authenticated-orcid":false,"given":"Azliyati","family":"Azizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"1254_CR1","first-page":"528","volume-title":"Fundamentals of the theory of Anibitiotcics","author":"NS \u0415gorov","year":"2004","unstructured":"\u0415gorov NS. Fundamentals of the theory of Anibitiotcics. \u041coscow: Science; 2004. p. 528."},{"issue":"10","key":"1254_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2478\/s11535-013-0209-6","volume":"8","author":"J Ziemska","year":"2013","unstructured":"Ziemska J, Rajnisz A, Solecka J. New perspectives on antibacterial drug research, Open life sciences. Centr Eur J Biol. 2013;8(10):943. https:\/\/doi.org\/10.2478\/s11535-013-0209-6.","journal-title":"Centr Eur J Biol"},{"issue":"1","key":"1254_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1743-422X-7-307","volume":"7","author":"Hyung-Jun Kwon","year":"2010","unstructured":"Kwon HJ, Kim HH, Yoon SY, Ryu YB, Chang JS, Cho\u00a0KO, Rho MC, Park SJ, Lee WS. In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virol J. 2010. https:\/\/doi.org\/10.1186\/1743-422X-7-307.","journal-title":"Virology Journal"},{"issue":"S12","key":"1254_CR4","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/nm1141","volume":"10","author":"Peter Palese","year":"2004","unstructured":"Palese P. Influenza: old and new threats. Nat Med. 2004;10(12 Suppl):S82\u20137.","journal-title":"Nature Medicine"},{"issue":"1","key":"1254_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","volume":"12","author":"Edwin D. Kilbourne","year":"2006","unstructured":"Kilbourne ED. Influenza pandemics of the 20th century.\u00a0Emerg Infect Dis. 2006; https:\/\/doi.org\/10.3201\/eid1201.051254.","journal-title":"Emerging Infectious Diseases"},{"key":"1254_CR6","doi-asserted-by":"publisher","unstructured":"MacLachlan NJ, Dubovi EJ,editors. Fenner\u2019s Veterinary Virology (Fifth Edition). Chapter 17. Paramyxoviridae and Pneumoviridae. Academic Press; 2017. p. 567\u20138. https:\/\/doi.org\/10.1016\/B978-0-12-800946-8.00017-9.","DOI":"10.1016\/B978-0-12-800946-8.00017-9"},{"key":"1254_CR7","doi-asserted-by":"publisher","unstructured":"Brown VR, Bevins SN. A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread.\u00a0Vet Res. 2017; https:\/\/doi.org\/10.1186\/s13567-017-0475-9.","DOI":"10.1186\/s13567-017-0475-9"},{"issue":"1","key":"1254_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1297-9716-42-122","volume":"42","author":"Jos CFM Dortmans","year":"2011","unstructured":"Dortmans JC, Koch G, Rottier PJ, Peeters BP. Virulence of Newcastle disease virus: what is known so far? Veterinary research. 2011; https:\/\/doi.org\/10.1186\/1297-9716-42-122.","journal-title":"Veterinary Research"},{"issue":"1","key":"1254_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virusres.2006.03.012","volume":"121","author":"Tatiana Bousse","year":"2006","unstructured":"Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T.Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Research. 2006; https:\/\/doi.org\/10.1016\/j.virusres.2006.03.012.","journal-title":"Virus Research"},{"issue":"2","key":"1254_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/antibiotics7020045","volume":"7","author":"Y\u014dko Takahashi","year":"2018","unstructured":"Takahashi Y, Nakashima T. Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics. Antibiotics (Basel). 2018; https:\/\/doi.org\/10.3390\/antibiotics7020045.","journal-title":"Antibiotics"},{"issue":"3","key":"1254_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.21307\/pjm-2018-048","volume":"67","author":"KATARZYNA JAKUBIEC-KRZESNIAK","year":"2018","unstructured":"Jakubiec-Krze\u015bniak K, Rajnisz-Mateusiak A, Guspiel A, Ziemska J, Solecka J. Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties. Pol J Microbiol. 2018; https:\/\/doi.org\/10.21307\/pjm-2018-048.","journal-title":"Polish Journal of Microbiology"},{"issue":"1","key":"1254_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2004.02.036","volume":"316","author":"Harumi Chiba","year":"2004","unstructured":"Chiba H, Inokoshi J, Nakashima H, Omura S, Tanaka H. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. Biochemical and Biophysical Research Communications. 2004; https:\/\/doi.org\/10.1016\/j.bbrc.2004.02.036.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"1254_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/B:WIBI.0000023824.20673.2f","volume":"20","author":"Doralice Rodrigues Sacramento","year":"2004","unstructured":"Sacramento DR, Coelho RRR, Wigg MD. World Journal of Microbiology and Biotechnology. 2004; https:\/\/doi.org\/10.1023\/B:WIBI.0000023824.20673.2f.","journal-title":"World Journal of Microbiology and Biotechnology"},{"issue":"8","key":"1254_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1248\/yakushi.124.469","volume":"124","author":"Masaru UYEDA","year":"2004","unstructured":"Uyeda M. Metabolites produced by actinomycetes--antiviral antibiotics and enzyme inhibitors. Yakugaku Zasshi: Journal Of The Pharmaceutical Society Of Japan. 2004; https:\/\/doi.org\/10.1248\/yakushi.124.469.","journal-title":"YAKUGAKU ZASSHI"},{"issue":"7","key":"1254_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/v10070356","volume":"10","author":"Fangfang Li","year":"2018","unstructured":"Li F, Chen D, Lu S, Yang G, Zhang X, Chen Z, Fan S, Wu S, He J. Anti-Influenza A Viral Butenolide from\u00a0Streptomyces\u00a0sp. Smu03 Inhabiting the Intestine of\u00a0Elephas maximus.\u00a0Viruses. 2018; https:\/\/doi.org\/10.3390\/v10070356.","journal-title":"Viruses"},{"issue":"3","key":"1254_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41429-018-0117-0","volume":"72","author":"T\u014dru Kimura","year":"2018","unstructured":"Kimura T, Suga T, Masanori K, Ueno M, Inahashi Yuki, Matsuo H,\u00a0 Iwatsuki M, Shigemura K, Shiomi K, Takahashi Y, \u014cmura S, Nakashima T. New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by Streptomyces sp. AM-2504. J Antibiot. 2018; https:\/\/doi.org\/10.1038\/s41429-018-0117-0.","journal-title":"The Journal of Antibiotics"},{"issue":"3","key":"1254_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2307\/1588616","volume":"14","author":"J. Spalatin","year":"1970","unstructured":"Spalatin J, Hanson RP, Beard PD. The haemagglutination-elution pattern as a marker in characterizing Newcastle disease virus. Avian Dis. 1970; https:\/\/doi.org\/10.2307\/1588616.","journal-title":"Avian Diseases"},{"key":"1254_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-621-0_3","volume-title":"Methods in Molecular Biology","author":"Alexander Klimov","year":"2012","unstructured":"Klimov A, Balish A, Veguilla V, Sun H,\u00a0Schiffer J,\u00a0Lu X,\u00a0Katz JM,\u00a0Hancock K. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol. 2012; https:\/\/doi.org\/10.1007\/978-1-61779-621-0_3."},{"issue":"3","key":"1254_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/JCM.02045-09","volume":"48","author":"Marcel Jonges","year":"2010","unstructured":"Jonges M, Liu W.M, der Vries E, van der Vries E,\u00a0Jacobi R,\u00a0Pronk I,\u00a0Boog C,\u00a0Koopmans M,\u00a0Meijer A,\u00a0Soethout E. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol. 2010;\u00a0https:\/\/doi.org\/10.1128\/JCM.02045-09.","journal-title":"Journal of Clinical Microbiology"},{"key":"1254_CR20","unstructured":"Li AF, Wang WH, Xu WF, Gong JZ. A microplate-based screening assay for neuraminidase inhibitors. Drug Discov Ther. 2009;3(6):260\u20135."},{"key":"1254_CR21","unstructured":"Guidelines for preclinical drug research. Part One. Ed. Mironova AN. Moscow: Grief and K, 2012. p. 350."},{"key":"1254_CR22","unstructured":"Schneider MA. Methodological issues of scientific development of antiviral drugs. Minsk: Science, 1977. p.150."},{"issue":"4","key":"1254_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.45.4.1162-1167.2001","volume":"45","author":"S. Bantia","year":"2001","unstructured":"Bantia S,\u00a0Parker CD,\u00a0Ananth SL,\u00a0Horn LL,\u00a0Andries K,\u00a0Chand P,\u00a0Kotian PL,\u00a0Dehghani A,\u00a0El-Kattan Y,\u00a0Lin T,\u00a0Hutchison TL,\u00a0Montgomery JA,\u00a0Kellog DL,\u00a0Babu YS. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir. Antimicrob. Agents and Chemother. 2001; https:\/\/doi.org\/10.1128\/AAC.45.4.1162-1167.2001.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"1254_CR24","unstructured":"Sidwell R. Ribavirin: A review of antiviral efficacy. Abstr. Recent. Res. Devel. In: Antimicrob. Agents and Chemother. (G. Pandalai, ed.) Research Signpost. India. 1995. V.1. p. 219\u201356."},{"key":"1254_CR25","doi-asserted-by":"publisher","unstructured":"Trenozhnikova L, Azizan A.\u00a0 Discovery of Actinomycetes from Extreme Environments with Potential to Produce Novel Antibiotics.\u00a0Central Asian Journal of Global Health. 2018; https:\/\/doi.org\/10.5195\/cajgh.2018.337.","DOI":"10.5195\/cajgh.2018.337"},{"key":"1254_CR26","unstructured":"Turmagambetova AS, Omirtaeva ES, Alexyuk MS, Bogoyavlenskiy AP, Berezin V.E. Estimation of therapeutic and prophylactic activities of new antiviral preparation of plant origin \u201cFlavovir\u201d in vitro and in vivo. News of the National Academy of Sciences, series of biological and medical sciences. 2016. http:\/\/kzpatents.com\/6-ip30638-kompozitnoe-antivirusnoe-sredstvo-rastitelnogo-proishozhdeniya-flavovir.html. Accessed 20 Aug 2019."},{"key":"1254_CR27","unstructured":"Turmagambetova AS, Zaitseva IA, Alexyuk MS, Alexuk PG, Bogoyavlenskiy AP, Berezin VE. Therapeutic and prophylactic activity of antiviral plant origin preparation \u201cvirospan\u201d in\u00a0in vitro\u00a0and\u00a0in vivo\u00a0experiments. Microbiology and Virology. 2016. http:\/\/kzpatents.com\/7-ip30933-kompozitnoe-antivirusnoe-sredstvo-rastitelnogo-proishozhdeniya-virospan.html. Accessed 20 Aug 2019."},{"key":"1254_CR28","doi-asserted-by":"publisher","unstructured":"Ogbole OO, Akinleye TE, Segun PA, Faleye TC, Adeniji AJ. In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses.\u00a0Virol J. 2018; https:\/\/doi.org\/10.1186\/s12985-018-1022-7.","DOI":"10.1186\/s12985-018-1022-7"},{"key":"1254_CR29","unstructured":"Drugbank. Rimantadine. 2005. https:\/\/www.drugbank.ca\/drugs\/DB00478. Accessed 28 Aug 2019."},{"key":"1254_CR30","unstructured":"Drugbank. Tamiflu. 2005. https:\/\/www.drugbank.ca\/drugs\/DB00198. Accessed 28 Aug 2019."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1254-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:54:18Z","timestamp":1606766058000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1254-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}